MGC Pharmaceuticals d.o.o
4 clinical trials · Sponsor
◉ Watch MGC Pharmaceuticals d.o.o
| Record | Firm | Date |
|---|---|---|
| Study of Safety and Efficacy of MGCND00EP1 as an Add on Treatment in Children and Adolescents With Resistant Epilepsies (NCT04406948) | MGC Pharmaceuticals d.o.o | 2024-05-30 |
| Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19 (NCT05037162) | MGC Pharmaceuticals d.o.o | 2022-10-11 |
| Clinical Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19 (NCT04802382) | MGC Pharmaceuticals d.o.o | 2021-06-11 |
| A Phase II, Controlled Clinical Study Designed to Evaluate the Effect of ArtemiC in Patients Diagnosed With COVID-19 (NCT04382040) | MGC Pharmaceuticals d.o.o | 2020-05-08 |
Track MGC Pharmaceuticals d.o.o automatically
Every clearance here is in the API, with alerts when new ones post.